Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Phospholipase C inhibitor]

Y Homma1, M Homma

  • 1Dept. of Biomolecular Sciences, Fukushima Medical College.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|October 6, 1997
PubMed
Summary
This summary is machine-generated.

N-myristoylated PCI peptide (myr-PCI) inhibits phospholipase C (PLC) activity and cell proliferation. Further modifications to PCI peptides aim to enhance PLC inhibition for potential therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Image Gallery: Cutaneous hydrophilic polymer emboli following thoracic endovascular aortic repair.

The British journal of dermatology·2019
Same author

Solution structure analysis of the periplasmic region of bacterial flagellar motor stators by small angle X-ray scattering.

Biochemical and biophysical research communications·2017
Same author

Effect of dose timing on the blood concentration of lapatinib in patients with breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Variables influencing patient satisfaction for hypnotics: difference between zolpidem and brotizolam.

Journal of clinical pharmacy and therapeutics·2014
Same author

Aprepitant does not alter prednisolone pharmacokinetics in patients treated with R-CHOP.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Neurological picture. Reversible posterior leukoencephalopathy syndrome caused by hanging.

Journal of neurology, neurosurgery, and psychiatry·2009
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Context:

  • Phospholipase C (PLC) signaling pathways are crucial in cellular processes.
  • Dysregulated PLC activity is implicated in diseases like familial adenomatous polyposis.
  • The N-myristoylated PCI peptide (myr-PCI) targets PLC isoforms.

Purpose:

  • To investigate the anti-PLC and anti-proliferative activities of modified PCI peptides.
  • To determine the minimal structural requirements for effective in vivo PLC inhibition.

Summary:

  • myr-PCI demonstrated inhibition of purified PLC isoforms and suppressed IP3 formation, DNA synthesis, and cell growth in KMS-8 cells.
  • Various acylated PCI peptide derivatives were synthesized and evaluated for their PLC inhibitory and anti-proliferative effects.

Related Experiment Videos

  • The study explores structure-activity relationships for developing potent PLC inhibitors.

    • Impact:

    • Findings will guide the development of novel therapeutic agents targeting PLC-mediated pathways.
    • Potential for new treatments for conditions associated with aberrant cell proliferation.
    • Contributes to understanding the structural basis of PLC inhibition.